ARCHIVES

Anamorelin Increases Body Mass In Two Global Phase III Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

DePinho’s Letter to the AAUP

May 30, 2014

ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals

September 20, 2013

QOL Of Anemic Patients Improved With Darbepoetin

June 28, 2002

Cancer Program Critic Epstein Invited To NCAB T Make Argument: “We’re Losing War In Cancer”

May 1, 1992

Kansas City Clinic Settles Medicare Overbilling Claim

June 6, 2014

Radiation Oncologists Form New College To Address Identity

April 12, 1991